United States · FDA National Drug Code directory
MAXALT-MLT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 78206-143_47257235-a46d-4fee-a29d-08f8ba8e46c2
- Product NDC
- 78206-143
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- rizatriptan benzoate
- Labeler
- Organon LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210601
- Source listing expiry
- 20271231
Source-listed ingredients
- RIZATRIPTAN BENZOATE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 CONTAINER in 1 CARTON (78206-143-01) / 3 POUCH in 1 CONTAINER / 1 BLISTER PACK in 1 POUCH (78206-143-99) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 78206-143-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →